We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 310.00 | 307.00 | 310.00 | 314.00 | 303.00 | 311.00 | 17,440 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/6/2021 11:05 | Thanks CT. Like every other follower of this message board, keenly looking forward for the day Hutchmed gets listed on HKSE (and Shanghai) SE and also how different HCM shares will be linked pari-passu in value. | sportii | |
12/6/2021 09:13 | Sportii, I assume a young journalist have their finger on the pulse. Are IFR a reputable source? Well they are under the Refinitiv umbrella, which most people are aware are owned by the London Stock Exchange. | cockneytrader | |
12/6/2021 07:43 | What is the reason for such vital information not getting covered anywhere else, including the company’s website? How come only ifre gets to know the information from ‘people with the knowledge of the matter’? | sportii | |
11/6/2021 17:46 | Asian listing gets green light hxxps://www.ifre.com | cockneytrader | |
09/6/2021 18:16 | "said people with knowledge of the matter." "said the people." | nerdofsteel | |
09/6/2021 12:00 | Yes I did see that post BUT you will be aware that the earlier post doesn't open up like the link I kindly provided.My wish is to be of service | steeplejack | |
09/6/2021 10:20 | Did you see the post before yours steeplejack? Over a day earlier and the same information LOL! Let's hope for some confirmation of this from the BOD now. Here is the link in an active format too. Only need to edit the lower-case "h" to an upper-case "H" to make links work. | lauders | |
09/6/2021 07:23 | https://www.ifre.com | steeplejack | |
07/6/2021 22:56 | No smoke without fire hxxps://www.ifre.com | cockneytrader | |
07/6/2021 21:27 | Been thinking that for ages. | its the oxman | |
07/6/2021 17:45 | Listing in Asia is imminent. | cockneytrader | |
04/6/2021 13:29 | Whatja, I think that this is what is behind HM's strategy for designing small molecule drugs that will be used in combination to enhance the efficiency of existing drugs and also the focus on low toxicity for new drugs that will differentiate them. | dbadvn | |
04/6/2021 13:06 | HCM got in last week rather than get lost in the noise from the bigger boys. AZ has published some great papers....it is easy to get lost in the technicalities but what ASCO ESMO etc tell me is that cures for cancers are getting better. It will take longer to prove new drugs are better than existing standard of care, so we will see fragmentation of the market so that each expensive drug has its own core zone of effectiveness where it will dominate but these will get narrower. | whatja | |
04/6/2021 11:17 | ASCO begins today - usually get a boost at this time | nerdofsteel | |
03/6/2021 07:09 | now that's an interesting thought Whatja! I did notice on the Asian Investor call when asked a question about possible listings CH immediately shut down the conversation "I am not going to comment on any possible Equity Capital Market activity" That implied something is going on | nerdofsteel | |
02/6/2021 12:18 | BTW I have seen that CK Life Sciences has popped 28% today in HK..there is no RNS equivalent. CKHH to combine Life sciences and Hutchmed? And generate HK listing? CKLS has a value of about £900m | whatja | |
02/6/2021 11:07 | I have long thought AIM needs a revamp....promotion to the main board should be compulsory once the map is above the ftse350 entry point for a given period. While it would reduce the AIM market it would encourage stewardship aligned with the value of the organisation. I suspect that many smaller companies would be better off on AIM.. | whatja | |
02/6/2021 11:05 | I’ve sold 2/3 over last week, had a great run as I’ve held since 2014 buying initially @115p. Still think it’s a good company but there are better risk/reward opportunities out there now. | rabiddog | |
02/6/2021 10:44 | Which is exactly why we need a main board UK listing and an Asian listing. | dbadvn | |
02/6/2021 10:34 | In "theory" hitting $1bn in annual revenues and becoming profitable should attract a mcap of $20bn, possibly more, based on average P/S and other metrics for the sector but who knows! The Company's valuation has tripled in a year on more than one occasion in the past so it's possible if we get a significant new pool of investors. | nerdofsteel | |
01/6/2021 14:57 | Steadied the ship It appears last week’s presentation has firmed up the share price with promises of a rich pipeline to drive a rapid commercialisation phase. There are still lots of regulatory hurdles to clear but the data presented looks promising. The US share price went through $30 a short while ago....the sinking feeling of a few weeks ago seems a distant memory. A doubling of the Market capitalisation with the 2025 targets being met seems quite possible. Atleast that is why I have my holding. | whatja | |
28/5/2021 05:56 | NASDAQ yesterday:- Volume 647,090 Avg. volume 232,040 | nerdofsteel | |
27/5/2021 16:37 | CH was very firm, he would NOT comment on any possible equity raising..... "I'm not gonna comment on specific equity capital market activities" | nerdofsteel |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions